Data / Drug companies / Guangzhou Renuma Medical Systems Co., Ltd
Guangzhou Renuma Medical Systems Co., Ltd: 11 products in the FDA NDC directory, labeler code 71742
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Guangzhou Renuma Medical Systems Co., Ltd (labeler code 71742) lists 11 products in the FDA National Drug Code Directory, covering 1 finished drug by generic name. By type: 11 over the counter drugs. Its main marketing category is unapproved homeopathic products. The newest product started marketing on October 31, 2017.
The request: Watch Guangzhou Renuma Medical Systems Co., Ltd (FDA labeler code 71742): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 71742
- Products in commercial distribution
- 11
- Packages
- 11
- Finished drugs by generic name
- 1
- Prescription products
- 0
- Over the counter products
- 11
- Flagged as original packager
- 11 of 11 products that carry the flag
- Started marketing in the last 12 months
- 0
- Products with a marketing end date set
- 1
- Earliest marketing start
- October 18, 2017
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Unapproved homeopathic products | 11 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 11 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Human growth hormone, hypophysis suis, hepar suis | 1 | 2 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Liquid | 11 | 100% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| HGH-Pro T020 | 71742-0014 | Liquid | Unapproved homeopathic products | October 31, 2017 |
| Thyro-Pro T019 | 71742-0013 | Liquid | Unapproved homeopathic products | October 26, 2017 |
| Spleen-Pro T018 | 71742-0012 | Liquid | Unapproved homeopathic products | October 26, 2017 |
| Respiro-Pro T016 | 71742-0010 | Liquid | Unapproved homeopathic products | October 26, 2017 |
| Glucose Control T015 | 71742-0009 | Liquid | Unapproved homeopathic products | October 26, 2017 |
| Heavy Metal Detox T014 | 71742-0008 | Liquid | Unapproved homeopathic products | October 26, 2017 |
| Sleep Well T012 | 71742-0006 | Liquid | Unapproved homeopathic products | October 24, 2017 |
| Female Vitality T010 | 71742-0004 | Liquid | Unapproved homeopathic products | October 20, 2017 |
| Vascu-Pro T009 | 71742-0003 | Liquid | Unapproved homeopathic products | October 19, 2017 |
| Arthri-Joint T008 | 71742-0002 | Liquid | Unapproved homeopathic products | October 19, 2017 |
| Neuro-Pro T007 | 71742-0001 | Liquid | Unapproved homeopathic products | October 18, 2017 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.